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Bioactive glasses (BG) are used to regenerate bone, as they degrade and release ther-
apeutic ions. Glass ionomer cements (GIC) are used in dentistry, can be delivered by 
injection, and set in situ by a reaction between an acid-degradable glass and a polymeric 
acid. Our aim was to combine the advantages of BG and GIC, and we investigated 
the use of alkali-free BG (SiO2–CaO–CaF2–MgO) with 0–50% of calcium replaced by 
strontium, as the beneficial effects of strontium on bone formation are well documented. 
When mixing BG and poly(vinyl phosphonic-co-acrylic acid), ions were released fast (up 
to 90% within 15 min at pH 1), which resulted in GIC setting, as followed by infrared 
spectroscopy. GIC mixed well and set to hard cements (compressive strength up to 
35 MPa), staying hard when in contact with aqueous solution. This is in contrast to GIC 
prepared with poly(acrylic acid), which were shown previously to become soft in contact 
with water. Strontium release from GIC increased linearly with strontium for calcium sub-
stitution, allowing for tailoring of strontium release depending on clinical requirements. 
Furthermore, strontium substitution increased GIC radiopacity. GIC passed ISO10993 
cytotoxicity test, making them promising candidates for use as injectable bone cements.
Keywords: bone cement, strontium, compressive strength, bioactive glass, bone filler
introduction
In 2010, about 5.5% of the EU population were diagnosed with osteoporosis, with 22% of women 
aged 50 and above (Hernlund et al., 2013). In osteoporosis, bone mass and density are reduced, owing 
to osteoclasts resorbing too much bone and osteoblasts not forming enough new bone, resulting in 
an increased risk of fractures. Incidences of clinical vertebral fractures in the EU have been reported 
to range from 170 to 470 per 100,000 (Hernlund et al., 2013), and about a third of these fractures 
can be persistently painful after non-operative care (Agency for Healthcare Research and Quality, 
2010). Vertebroplasty and kyphoplasty are common procedures which restore fractured vertebrae 
by injecting a bone cement such as poly(methyl methacrylate) (PMMA) (Lewis, 2006), and the aim 
is to relieve pain while restoring dimensions and strength of the vertebrae. Glass ionomer cements 
(GIC) have the potential to overcome some of the limitations of acrylic cements, such as shrinkage 
during polymerization and a highly exothermic setting reaction, as they set by an acid–base reaction 
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between a polymeric acid [such as poly(acrylic acid), PAA] and 
a degradable glass (Wilson, 1996). Furthermore, GIC form a 
chemical bond to bone (Wilson et al., 1983), which is in contrast 
to acrylic cements, where mechanical stability is achieved by 
mechanical interlocking only.
Several commercial dental GIC contain strontium in the glass 
component (Stamboulis et al., 2004), and the release of strontium 
ions has been shown to enhance tooth remineralization (Thuy 
et al., 2008) and promote antibacterial properties (Guida et al., 
2003; Brauer et al., 2013), particularly in synergy with fluoride 
ions (Dabsie et al., 2009). Furthermore, strontium ions are known 
to enhance osteoblastic bone formation and reduce osteoclastic 
bone resorption (Marie et al., 2001), and they are used for the 
treatment of osteoporosis (Marie, 2005). Strontium-containing 
bioactive glasses (BG) have been shown to release strontium 
ions when in contact with aqueous solutions (Fredholm et  al., 
2012), and they have been suggested to combine the benefits of 
strontium ions with those of BG (bioactivity, apatite formation, 
controlled release of therapeutic ions, and delivery versatility) 
(Gentleman et al., 2010; Autefage et al., 2015).
Dental GIC contain aluminum ions, which play an important 
role in both glass degradation (hydrolysis of Si–O–Al bonds) and 
in stability of the cements (cross-linking of PAA chains by Al3+); 
however, as they are neurotoxic (Joshi, 1990) and negatively affect 
bone mineralization (Cournot-Witmer et al., 1981; Boyce et al., 
1982; Blades et al., 1998), dental GIC are not ideal for orthopedic 
applications. Efforts have been made to replace aluminum with 
iron (Hurrell-Gillingham et al., 2006) or zinc (Darling and Hill, 
1994); however, these also have drawbacks and particularly too 
high a zinc release has been shown to result in cytotoxic reactions 
(Brauer et al., 2011a). Materials based on magnesium-containing 
BG can therefore provide a promising alternative.
In previous studies, GIC based on magnesium-containing BG 
and PAA have been shown to be promising candidates for use as 
bone cements (Brauer et al., 2011a, 2013) and to show antibacte-
rial properties (Brauer et al., 2013). However, their mechanical 
properties and hydrolytic stability were poor compared to GIC 
using aluminum- or zinc-containing glasses (Brauer et al., 2011a). 
Our hypothesis was that a polyelectrolyte with a larger concen-
tration of functional groups would allow for formation of more 
hydrolytically and mechanically stable GIC, and here we there-
fore prepare GIC with poly(vinylphosphonic-co-acrylic acid) 
(PVPA–PAA) rather than PAA.
Our aim was to characterize the setting behavior, mechani-
cal properties, ion release, and in vitro cell compatibility of GIC 
based on PVPA–PAA and BG (SiO2–CaO–CaF2–MgO) with 0, 
2.5, 10, or 50% of Ca replaced by Sr on a molar base.
Materials and Methods
glass synthesis and characterization
Bioactive glasses (SiO2–CaO–CaF2–MgO) where either no 
calcium (Sr0) or 2.5, 10, or 50% of calcium (Sr2.5, Sr10, Sr50) 
were replaced by strontium on a molar base (Table  1) were 
prepared using a standard melt-quench route as described previ-
ously (Brauer et al., 2013). Glasses were mixed with isopropanol 
and ground for 50 min in an agate planetary mill (Pulverisette, 
Fritsch GmbH, Idar-Oberstein, Germany) and then sieved using 
a 40  μm analytical sieve. The amorphous state of the glasses 
was investigated using powder X-ray diffraction (XRD; D5000, 
Siemens) using CuKα radiation and then measured with a step 
time of 31 s and step width of 0.02° in the range of 10°–60° 2Θ. 
Thermal properties of the glasses were analyzed using differen-
tial thermal analysis (DTA; DTA-50, Shimadzu; heating rate, 
10  K  min−1). Glass composition was analyzed using scanning 
electron microscopy with energy-dispersive X-ray spectroscopy 
(EDX) with fluoride (Field Emission JEOL 7001 F, EDAX Trident 
EDX; Kα; 25 keV).
glass Dissolution
Glass solubility was analyzed in a hydrochloric acid/potassium 
chloride (HCl/KCl) buffer, which was obtained by mixing 134 mL 
of 0.2 mol L−1 hydrochloric acid solution (Titrisol, Merck, p.a.) 
with 50 mL of 0.2 mol L−1 potassium chloride (VEB Jenapharm 
Laborchemie Apolda, p.a.) solution, filling to a total volume of 
200 mL and storing at 37°C. Seventy-five milligrams of glass pow-
der was immersed in 50 mL buffer solution and stored at 37°C for 
5, 15, 60, 360, or 1440 min. Afterward, solution and remaining 
powder were separated by filtering using medium porosity filter 
paper (5 μm particle retention, VWR). The remaining powder 
was analyzed using attenuated total reflectance Fourier trans-
form infrared spectroscopy (ATR-FTIR; Alpha, Bruker Daltonic 
GmbH, Bremen, Germany) and the solutions were analyzed 
using inductively coupled plasma optical emission spectroscopy 
(ICP-OES; Varian Liberty 150, Agilent Technologies, Böblingen, 
Germany). Data represent mean ± standard deviation (SD).
cement Formation
Before mixing cements, glass powders were annealed by heating 
to and holding for 10 min at 50 K below glass transition before 
being allowed to cool to room temperature. Cements were 
prepared using poly(vinyl phosphonic-co-acrylic acid) (PVPA–
PAA; 40 wt% solution; weight average chain length between 40 
and 70 kD according to manufacturer), which was provided by 
First Scientific Dental GmbH (Elmshorn, Germany). Cements 
were obtained by mixing glass powder and polymer solution in 
a weight ratio of 2:1, giving the cement into PTFE molds (4 mm 
in diameter; 7 mm in height) and allowing to set inside the mold 
for 60 min at 37°C.
cement setting Behavior and Mechanical 
Properties
Cement setting was followed by ATR-FTIR, by placing the freshly 
mixed cement onto the diamond window of the spectrometer and 
obtaining a spectrum every 5 min for up to 60 min. FTIR spectra 
of the untreated glasses and PVPA–PAA solution were measured 
for comparison.
Mechanical properties of the cements were measured on 
specimens which (after setting at 37°C for 60 min) were removed 
from the mold and kept for 23 h either in deionized water or at 
100% relative humidity (100% RH) at 37°C. For storing at 100% 
RH, specimens together with some damp tissue were placed 
inside a closed container; physical contact between specimen and 
tissue was avoided. Specimens without treatment in deionized 
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water or at 100% RH (thus set for 60  min at 37°C inside the 
mold only) were analyzed as controls. Compressive strength 
and Young’s modulus were measured using a hydraulic testing 
machine (Zwick 1445, Zwick GmbH, Ulm, Germany) with a 
10 kN load cell at a test velocity of 1 mm min−1. Per composition, 
10 separate specimens were tested. Results were analyzed using 
one-way analysis of variance (ANOVA; Origin 8.5.0, OriginLab 
Corp., Northampton, MA, USA) followed by Bonferroni post hoc 
test; p ≤ 0.05 was considered significant. Results are presented as 
mean ± confidence interval.
radiopacity
Glass ionomer cement radiopacity was measured according to 
the specifications laid out in BS EN ISO 9917-1:2007 standard 
for water-based dental cements. One-millimeter-thick GIC disks 
10 mm in diameter were prepared by packing the cement mixture 
into Teflon molds of the same dimensions. GICs were allowed to 
set in the molds for 1 h while clamped between two acetate sheets. 
Thereafter, the disks were stored at 37°C and 100% RH. After 24 h, 
the samples were removed from the molds and radiographed, 
along with a six-step aluminum step wedge (0.5 to 5.0  mm), 
using a digital X-ray unit. The samples and the step wedge were 
irradiated at 65  kV from a distance of 10  cm. Exposure time 
was 0.4 s. Exact height of the cement disks was measured using 
a micrometer, and measured radiopacity was normalized to a 
specimen height of 1.0 mm. Measurements were performed in 
triplicates and results are presented as mean ± SD.
cell culture, cement cytotoxicity (isO 10993), 
and ion release
MC3T3-E1 mouse osteoblasts were obtained from the European 
Collection of Cell Cultures (Salisbury, UK) and cultured under 
standard conditions (37°C, 5% CO2/95% air, 100% RH) in Alpha 
Minimum Essential Medium (αMEM) supplemented with 10% 
(v/v) fetal bovine serum (FBS) and 2 mM l-glutamine (all from 
Invitrogen, Paisley, UK).
To create conditioned media for cytotoxicity testing (ISO 
10993:5), 10 mm diameter, 1 mm thick cement disks, organo-tin 
stabilized poly(vinyl chloride) (PVC) sheet (positive control), 
and non-toxic PVC (noDOP®) tubing (negative control) were 
prepared. Positive and negative control samples were provided by 
Raumedic (Münchberg, Germany) and sterilized in 70% ethanol 
for 1 h. Cement samples were sterilized under UV light for 2 h 
on each side.
Conditioned media were created by soaking cement samples 
or positive and negative control samples in αMEM for 7  days 
at 37°C. A material surface area to culture medium volume 
ratio of 3 cm2 mL−1 was maintained as directed in ISO10993:5. 
TaBle 1 | nominal glass composition (mol%) and strontium for calcium substitution (%).
glass siO2 caO caF2 srO srF2 MgO substitution
Sr0 47.32 10.41 11.04 – – 31.23 0
Sr2.5 47.32 10.15 10.76 0.26 0.28 31.23 2.5
Sr10 47.32 9.37 9.93 1.04 1.10 31.23 10
Sr50 47.32 5.21 5.52 5.21 5.52 31.23 50
Cells were seeded at 20,000 cells/cm2 in 96-well plates in basal 
medium and allowed to attach for 24 h. Culture medium was then 
exchanged with conditioned medium supplemented with 10% 
FBS and 2 mM l-glutamine. Conditioned medium was added to 
cells either neat or diluted by factors of 2, 4, 8, or 16 with basal 
medium and allowed to incubate for 24 h. Cell metabolic activity 
was determined by MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide; Sigma-Aldrich, Dorset, UK) assay, 
as previously described (Gentleman et al., 2010). Briefly, 20 μL 
of a 5 mg/mL solution of MTT in phosphate buffered saline was 
added to each well and plates were returned to the incubator for 
4 h. Culture medium was then removed, the formazan product 
dissolved in dimethyl sulfoxide, and the solution’s absorbance was 
read on a colorimetric plate reader at 592 nm. Data represent mean 
(± SD) of three separate samples for each composition or control 
and are normalized to negative controls. Statistical analysis of 
MTT activity was carried out by ANOVA followed by post hoc 
Tukey test and was limited to comparisons carried out with the 
non-diluted conditioned medium. Differences were considered 
significant if p < 0.05. Ions released into the cell culture medium 
were analyzed using ICP-OES (calcium, strontium, magnesium, 
and silicon) and fluoride-selective electrode (fluoride). For ICP-
OES analysis, solutions were diluted by a factor 1:20 and acidified 
using 69% nitric acid before analysis. Fluoride concentrations 
were measured using a fluoride ion selective electrode (Elit 8221, 
Nico2000 Ltd.) with a AgCl reference electrode.
results
glass characterization
All glasses were amorphous according to powder XRD results, 
with XRD patterns displaying the typical amorphous halos 
(Figure  1A). Significant amounts of fluoride were lost during 
melting (Brauer et  al., 2011b), resulting in overall changes in 
the glass compositions as presented in Table  2. DTA curves 
(Figure 1B) and summarized thermal properties (Table 3) show 
comparable thermal behavior for glasses Sr0, Sr2.5, and Sr10 but 
lower glass transition and higher crystallization temperatures for 
Sr50.
glass Dissolution
Experiments were performed in a buffer solution set to pH 1, as 
this was the pH of the PVPA–PAA solution. Upon immersion of 
glass powders, a fast pH rise was observed (Figure 2A). A pH of 
1.15 was reached within the first few minutes and pH 1.2 at 6 h, 
where it remained for the duration of the experiment (24 h). This 
was accompanied by a release of ions (Figure 2B), where a very fast 
release was observed within the first minutes of the experiments, 
TaBle 3 | DTa results: glass transition (Tg), crystallization onset (Tc,o), 
and crystallization peak (Tc,p) temperatures (°c), error is ±5 K.
glass Tg Tc,o Tc,p
Sr0 644 751 785
Sr2.5 637 753 789
Sr10 649 754 786
Sr50 635 760 813
TaBle 2 | eDX results compared to nominal glass composition (mol%; 
fluoride content presented as F; ca and sr presented as oxides only).
glass siO2 caO srO MgO F
Sr0 42.62
45.2 ± 0.3
9.38
20.56 ± 0.07 –
28.13
28.8 ± 0.1
19.88
5.4 ± 0.1
Sr2.5 42.62
41.9 ± 0.5
9.14
23.31 ± 0.05
0.23
1.03 ± 0.01
28.13
22.8 ± 0.2
19.88
10.9 ± 0.2
Sr10 42.62
40.3 ± 0.5
8.44
20.12 ± 0.04
0.94
2.38 ± 0.01
28.13
21.6 ± 0.2
19.88
15.6 ± 0.2
Sr50 42.62
37.8 ± 0.4
4.69
11.84 ± 0.01
4.69
11.30 ± 0.07
28.13
22.8 ± 0.2
19.88
16.3 ± 0.2
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and concentrations increased more slowly afterward. Absolute 
concentrations shown in Figure  2B correspond to a release of 
about 90% of calcium and 75% of strontium and magnesium 
ions within the first hour, reaching 100 and 90%, respectively, at 
24 h. Release of silicon ions ranged from about 10% at 5 min to 
20% at 24 h. This ion release caused structural changes observed 
by FTIR, where the non-bridging oxygen band at 930 cm−1 had 
already disappeared at an immersion time of 5  min, and no 
pronounced changes in FTIR spectra were observed afterwards 
(Figure 2C). Release of Mg2+ and silicon ions did not vary much 
with strontium for calcium substitution in the glass. By contrast, 
concentrations of Ca2+ ions decreased with strontium for calcium 
substitution in the glass (owing to lower amounts of Ca2+ ions 
present in the glass) and concentrations of Sr2+ ions increased 
linearly (R2 = 0.999; Figure 2D).
cement Formation and Properties
Cements from PVPA–PAA and glasses Sr0 and Sr2.5 showed 
very good mixing properties; however, with increasing strontium 
for calcium substitution, the glasses became more reactive and 
working times shorter, with glass Sr50 setting very quickly. All 
glasses, when mixed with PVPA-PAA solution, set to hard and 
brittle cements within 1 h at 37°C. Cements stayed hard when 
stored in water or at 100% RH.
Poly(vinylphosphonic-co-acrylic acid) solution showed pro-
nounced bands at about 1715, 1640, 1170, 995, and 930 cm−1, with 
additional low-intensity bands at 1455 and 1415 cm−1 (Figure 3). 
Upon mixing with the glass powder, the band at 1715 cm−1 disap-
peared, new bands appeared at 1560, 1050, and 977 cm−1, and 
the two bands at 1455 and 1415 cm−1 increased in intensity. The 
band at 1715 cm−1 can be assigned to the symmetric stretch of 
the carboxylic –C=O band (Socrates, 2004). Upon reaction with 
the glass and formation of the polysalt matrix, i.e., a change from 
mostly carboxyl (–COOH) to carboxylate groups (–COO−), 
the –C=O band disappeared, owing to the π electrons in the 
carboxylate group being delocalized. A similar effect is observed 
with the –P=O stretch vibration band at 1170  cm−1 (Socrates, 
2004), which also disappeared once the salt matrix of the GIC 
has formed. The band at 1642 cm−1 may be related to –C=O or 
possibly –P=O bonds, connected by hydrogen bonds (Socrates, 
2004), and the intensity also decreased upon salt formation. The 
band at 1050 cm−1 is most likely related to P–O vibrations in the 
salt matrix, while the high intensity band formed at 1560 cm−1 
and the double band at 1455 and 1415  cm−1 are related to 
asymmetric and symmetric –COO− stretch bands, respectively 
(Socrates, 2004).
FigUre 1 | (a) XRD patterns of the glasses, showing the typical amorphous halo. (B) DTA traces of the glasses, showing glass transition temperatures (Tg) 
highlighted by arrows and crystallization exotherms.
FigUre 2 | changes in (a) ph, (B) concentrations of ions in hcl/Kcl buffer, and (c) FTir spectra with immersion time of glass sr10. (D) Changes in 
concentrations of ions with strontium for calcium substitution in the glass for glasses immersed in HCl/KCl buffer for 15 min (solid line: linear regression; R2 = 0.999).
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Cements gave average compressive strength of at least 20 MPa 
and Young’s moduli of 4 GPa and above (Figures 4A,B, respec-
tively). There seemed to be no clear trend in mechanical proper-
ties (average compressive strength or Young’s modulus) with glass 
composition; but both compressive strength and Young’s modulus 
seemed to increase with storage time in water and particularly at 
100% RH. Maximum compressive strength was between 38 and 
39 MPa for cements made from Sr0 and Sr2.5 at 24 h at 100% RH, 
while maximum compressive strength obtained for cements from 
glasses Sr10 and Sr50 were between 30 and 35 MPa (Figure 4C). 
Maximum Young’s moduli showed no clear trend but seemed to 
decrease with increasing strontium for calcium substitution in 
the glass (Figure 4D).
Radiopacity increased with increasing strontium for calcium 
substitution in the glass (Figure 5A), showing a linear increase 
for substitutions from 2.5 to 50% (R2  =  0.999; Figure  5B). 
Cements from glass Sr10 showed radiopacity comparable to that 
of aluminum, while radiopacity of cements from glasses Sr0 and 
Sr2.5 was lower and that of Sr50 well above it (225% of that of 
aluminum). The radiopacity of cement from glass Sr0 was off 
scale, i.e., lower than the first step of the step wedge (0.5 mm Al), 
and it is therefore not included in Figure 5B.
cytotoxicity and ion release into  
cell culture Medium
MC3T3-E1 cells exposed to conditioned medium soaked with the 
negative control had normal morphologies, whereas those cul-
tured with conditioned medium soaked with the positive control 
had abnormal rounded morphologies and often detached from 
the culture surface (Figures 6A,B, respectively). Quantification 
FigUre 3 | changes in FTir spectra with setting time for cements 
made using glass sr10. Spectra of PVPA–PAA solution and the untreated 
glass are given for comparison.
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of cell metabolic activity by MTT assay demonstrated that cells 
exposed to conditioned medium soaked with the positive control 
had significantly lower metabolic activity than those exposed 
to conditioned medium soaked with the negative control (non-
diluted, p < 0.001) (Figure 7A). MC3T3-E1 exposed to medium 
soaked with cements made from glasses Sr0 to Sr10 had normal 
morphologies (Figures  6C–E) and their metabolic activities 
were never significantly lower than that of the negative control. 
Cells exposed to medium soaked with cement from glass Sr50 
contained cells with normal morphologies but also some rounded 
cells (Figure 6F); however, their metabolic activity was not sig-
nificantly different from that of the negative control (p > 0.05).
Concentrations of Mg2+, Ca2+, F−, and silicon ions in cell 
culture medium soaked with cements from glasses Sr0 to Sr50 
did not vary greatly with glass composition. The only exception 
were the concentrations of Sr2+ ions, which increased linearly 
(R2 = 0.999) with strontium for calcium substitution in the glass 
(Figure 7B).
Discussion
Bioactive glasses are successfully used to regenerate bone; they 
degrade in physiological solutions and release ions to stimulate 
bone formation. When in contact with aqueous solutions, par-
ticularly at low pH (Bingel et al., 2015), BGs show a fast release 
of modifier ions (Hoppe et  al., 2011; Brauer, 2015), including 
sodium, calcium, strontium, or magnesium ions (Fredholm et al., 
2012; Bingel et al., 2015; Blochberger et al., 2015). This ability of 
BG to release ions can also be exploited for preparing GIC. The 
glasses in the present study were shown to release ions fast when 
in contact with a solution of a pH comparable to that of the PVPA–
PAA solution used (Figure 2B), with the majority of ions being 
released during the first 5 min of immersion. Over the remaining 
time of the experiment (up to 24  h) ionic concentrations kept 
increasing, but much more slowly. When following changes in 
glass structure during immersion by FTIR (Figure 2C), it became 
obvious that indeed after the initial dramatic changes over the 
first 5  min (where the non-bridging oxygen band disappeared 
nearly completely) no pronounced structural changes seemed to 
occur.
Dental GICs set by a neutralization reaction between a 
polymeric acid and an acid-degradable (fluoro–) aluminosilicate 
glass (Wilson, 1996). In aluminosilicate glasses, aluminum, 
an intermediate element according to Dietzel’s rules (Dietzel, 
1941), has been shown to be present in fourfold coordination 
mostly, forming Si–O–Al bonds and AlO4
−  groups, which are 
charge-balanced by modifier cations (Neuville et al., 2006). These 
Si–O–Al bonds are readily hydrolyzed at low pH (Griffin and Hill, 
1999), allowing for rapid glass degradation and ion release, which 
enables the GIC to set by formation of ionic bridges between car-
boxylate groups by metal cations such as Al3+. As aluminum ions 
are known to be neurotoxic (Joshi, 1990) and negatively affect 
bone mineralization (Cournot-Witmer et al., 1981; Boyce et al., 
1982; Blades et al., 1998), magnesium ions have been studied as 
a possible alternative.
This makes the use of magnesium-containing BG of particu-
lar interest here, as it has been suggested that MgO acts as an 
intermediate oxide in BG, partially entering the silicate network 
(Watts et al., 2010). This would mean that some magnesium is 
present as Si–O–Mg bonds, which may be acid hydrolyzable in 
analogy to Si–O–Al bonds in dental GIC (Griffin and Hill, 1999). 
And although recent results showed that there is no pronounced 
difference in the release patterns of Ca2+ and Mg2+ ions from BGs 
(Blochberger et  al., 2015), Mg2+ ions with their smaller ionic 
radius compared to calcium ions [Mg2+ 0.072 nm; Ca2+ 0.100 nm; 
both sixfold coordination (Shannon, 1976)] and thus higher 
field strength may be of interest for effective cross-linking of the 
carboxylate groups in the GIC matrix.
Cement setting and subsequent mechanical properties are 
influenced by a range of (to some extent interconnected) factors. 
Ion release from the glass has a strong influence on cement set-
ting, and working and setting time are likely to depend on how 
fast ions are actually released from the glass. Ion field strength is 
likely to affect both cement setting and mechanical properties, 
with small cations of high charge, e.g., Al3+, resulting in better 
setting and improved mechanical properties compared to, e.g., 
alkaline earth metal cations. The polymeric acid component has 
also been shown to affect setting and mechanical properties, with 
molecular weight being one factor here and other factors includ-
ing the type and number of functional groups per monomer 
unit (Hill et al., 1989; Griffin and Hill, 1998). These functional 
groups were observed in FTIR spectra (Figure 3), and the spectra 
allowed for following the reaction between PVPA–PAA and the 
glass, particularly by the decrease in intensity of carboxyl and 
phosphonic acid groups, and the increase in intensity of the cor-
responding salt bands.
In the present study, we did not see a pronounced influence of 
glass composition on GIC mechanical properties (Figure 4), but 
maximum Young’s moduli seemed to decrease with increasing 
strontium for calcium substitution in the glass (Figure 4D). This 
may be explained by the larger ionic radius of Sr2+ compared to 
Ca2+, which can be expected to result in it being a slightly less 
FigUre 4 | Mean (a) compressive strength and (B) elastic modulus and maximum (c) compressive strength and (D) elastic modulus obtained from 
compression tests on cement samples.
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effective ion for cross-linking of the polycarboxylate chains. It 
was also noticeable that the glass with the highest strontium for 
calcium substitution showed a shorter working time and poorer 
mixing properties than glasses with lower substitutions. Indeed, 
it was very difficult to obtain a homogeneously mixed cement of 
glass Sr50 unless the glass powder was annealed first to reduce 
its reactivity. For all other glass compositions, it was possible 
to obtain cements from both annealed and non-annealed glass 
powders, although annealing resulted in increased working 
times and easier mixing. This influence of strontium for calcium 
substitution is likely to be related to the ion release from the 
glass. Relative ion release, i.e., the percentage of ions released 
from a glass, has been shown to increase with strontium for 
calcium substitution in BG (Fredholm et al., 2012) owing to a 
lower oxygen density, i.e., an expanded silicate network, in the 
glass (Fredholm et al., 2010; Du and Xiang, 2012), caused by the 
larger ionic radius of Sr2+ ions compared to Ca2+ ions (Martin 
et  al., 2012). The same effect is likely to have influenced not 
only ion release and subsequent cement setting in the present 
study but also the lower Tg and crystallization temperature 
(Lotfibakhshaiesh et al., 2010) observed for glass Sr50 (Table 1). 
The effect of annealing on working times may possibly be 
explained by the removal of surface stresses introduced during 
the grinding process.
In our previous study, we showed that GIC prepared from the 
same glass compositions but using PAA (rather than PVPA–PAA) 
as the polymeric acid exhibited poor hydrolytic stability (Brauer 
et  al., 2011a, 2013), with the cements becoming soft when in 
contact with water. In the present study, all cements stayed hard 
during storage in either water or at 100% relative humidity. This 
difference was probably caused by differences in the functional 
groups of the polymers, as PAA only has one carboxyl group per 
repeating unit, while PVPA–PAA has a phosphonic acid group, 
i.e., a diprotic acid group, in addition to the carboxyl group 
FigUre 6 | Mc3T3-e1 cells cultured for 24 h in conditioned medium 
soaked with (a) negative and (B) positive control and (c–F) cements 
prepared with glasses sr0 to sr50. Examples of cells with normal 
morphologies are indicated with white arrows; cells with poorly spread 
morphologies are indicated with black arrows (scale bar is 200 μm).
FigUre 5 | (a) Radiographic images of cement disks and aluminum step 
wedge and (B) radiopacity of cement disks (1 mm in height) vs. strontium for 
calcium substitution in the glass. Dashed line is linear regression (R2 = 0.999).
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(Figure  8). This provides for more protons to attack the glass 
but also, once deprotonated, for more ionic cross-links to form 
between metal cations and the polymeric acid.
The radiopacity of implants is often increased in order to enable 
or facilitate visualization of the material during medical imaging 
such as radiography or fluoroscopy, and radiopacifiers such as 
barium sulfate are commonly added to cement systems including 
acrylic cements (Jasper et al., 2002). Density and atomic number 
are two main factors influencing the radiopacity of a material, 
and if high atomic number elements are present in a material, it 
can be expected to possess an inherent radiopacity. Incorporation 
of strontium into calcium phosphate cements has been shown 
to increase their radiopacity (Schumacher and Gelinsky, 2015), 
and in a similar effect, increasing strontium for calcium substitu-
tion in the glass, and thus the presence of increasing amounts of 
strontium ions in the GIC, made the GIC in the present study 
increasingly radiopaque (Figure 5).
Comparing the radiopacity of these GICs to that of bone 
slices of the same thickness is complicated owing to the lack of 
available literature. Radiographic images of alveolar sockets and 
surrounding bone, however, showed radiographic densities of 
about 1.6 mm Al (Fernandes Gomes et al., 2006). While no exact 
thickness of the bone was given, the thickness was more than 
1 mm (i.e., more than the thickness of our GIC specimens here), 
as the radiographs showed the entire jawbone. This suggests that 
the radiopacity of the GIC prepared with Sr50 is well above that 
of bone and that even a lower strontium for calcium substitution 
(e.g., 30–40%) might be sufficient to obtain radiopaque cements, 
which would show in a radiograph.
If implant materials are used to fill bone defects, their role as 
void filler can be combined with a role as a release device for 
therapeutic agents. For inorganic implant materials, such as BG 
FigUre 8 | structures of repeating units of (a) Paa and  
(B) a copolymer of acrylic acid and vinylphosphonic acid.
FigUre 7 | (a) Cytotoxicity assessment (ISO10993:5): Normalized MTT activity of MC3T3-E1 cells cultured for 24 h in conditioned medium (undiluted and diluted 
by factors 1:2 to 1:16) soaked with negative or positive control or cements made from glasses Sr0 to Sr50. (B) Concentrations of ions in cell culture medium vs. 
strontium for calcium substitution in the glass (solid line: linear regression; R2 = 0.999).
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or GIC, an easy way of achieving this is by incorporating ions 
which can be released into the body and perform their therapeutic 
action there (Hoppe et al., 2011). Key is here to keep ionic con-
centrations in the range where therapeutic benefits are obtained 
but no toxic effects are observed. Therefore, caution should be 
exercised when substituting reportedly therapeutic ions into BG 
or GIC. Although zinc, for example, plays a number of essential 
biological roles in the body, particularly in bone formation, toxic-
ity can result if the concentrations released are too high (Brauer 
et al., 2011a).
Glass ionomer cement studied here released various ions 
originating from the BG, but did not show any cytotoxic effects 
according to ISO 10993:5 (Figure 7). Instead, they performed 
at least as well as the non-toxic PVC control. GICs released 
about 1.5–2 mM of silicon ions (Figure 7B), originating from 
degradation of the BG silicate matrix. Ionic dissolution products 
from BG have been shown to increase osteoblast proliferation 
via gene upregulation (Xynos et al., 2000), and silicon ions are 
thought to play a key role here (Hoppe et al., 2011). The great 
benefit is that supplementation with growth factors is not neces-
sary when using BG, owing to the stimulatory effects of silicon 
and also calcium ions (Jones, 2013). If BGs are incorporated into 
GIC, comparable benefits through ion release may possibly be 
observed.
Apart from adding radiopacity to the cements, the presence 
of strontium in the glass allowed for the release of strontium ions 
(Figure  7B), which, when released from BG, showed anabolic 
and anticatabolic effects in vitro (Gentleman et al., 2010). And, 
indeed, strontium ions are the active component in a drug for 
the treatment of osteoporosis (Marie, 2005; Bonnelye et  al., 
2008). In the present study, strontium concentrations in cell 
culture medium were between 0.1 (Sr2.5) and 2.2  mM (Sr50), 
which corresponds to a concentration range from 9 to 192 ppm. 
Concentrations in a similar range were recently shown to 
stimulate osteoblasts (25 ppm) and inhibit osteoclasts (80 ppm) 
(Gentleman et al., 2010). Strontium ions released from GIC have 
also previously been shown to have antibacterial properties and 
reduce cell counts of Streptococcus faecalis or Staphylococcus 
aureus when present in concentrations between 0.16 and 2.5 mM 
(Brauer et al., 2013).
The benefits of fluoride ions in preventing dental caries are 
well documented (Featherstone, 2000), and, indeed, the release 
of fluoride ions is one of the advantages of using dental GIC 
(Ewoldsen and Demke, 2001). However, fluoride ions also affect 
bone health. As high concentrations of fluoride, traditionally 
administered orally as sodium fluoride, are not effective in 
preventing fractures (Aaseth et  al., 2004), its use for treating 
osteoporosis was dismissed for several years. Recently, however, 
the use of low fluoride concentrations, in combination with 
other therapeutic agents, is being reexamined (Reid et al., 2007). 
In addition, synergistic effects of fluoride and strontium ions in 
promoting antibacterial activity have been suggested (Dabsie 
et  al., 2009). Cell culture studies on fluoride-releasing BGs 
showed that low concentrations of fluoride released from the 
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glass (between 1.5 and 1.8 ppm) enhanced cell attachment and 
proliferation, while initial high release of fluoride ions (between 
10 and 35 ppm) followed by much reduced release (0.3 to 2 ppm) 
through formation of a protective fluoroapatite surface layer on 
the BGs showed significantly increased alkaline phosphatase 
(ALP) activity, a marker for mineralization, indicating that flu-
oride-containing BGs can direct cell differentiation (Gentleman 
et al., 2013). In the present study, fluoride concentrations in the 
culture medium were between 3 and 6 mM (corresponding to 
60–100 ppm), indicating that lower fluoride concentrations in 
the glass component (and subsequently in the GIC) may be 
advantageous.
The GICs studied here also released magnesium ions, and 
concentrations in undiluted cell culture medium ranged from 
about 8 to 10 mM. Magnesium ions present in and released from 
BGs have been shown to reduce apatite precipitation (Diba et al., 
2012; Blochberger et  al., 2015), but some beneficial effects on 
osteoblast proliferation, differentiation, and ALP activity have 
been suggested (Hoppe et al., 2011).
Taken together, our results show that it is possible to prepare 
mechanically and hydrolytically stable GICs from BGs free of 
aluminum or zinc ions, which allow for the release of reportedly 
therapeutic ions. Further experiments are necessary, however, to 
investigate if the release of fluoride, strontium, silicon, or mag-
nesium ions from GIC does indeed have comparable beneficial 
effects as those demonstrated in previous studies on BG.
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